Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents

To determine the efficacy and safety of atomoxetine in the treatment of ADHD in children and adolescents.

This is a protocol.

Health topics:

Published:

18 April 2012

Authors:

Kallapiran GK, Mammen P, Tharyan P, Russell P

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Kallapiran GK, Mammen P, Tharyan P, Russell P. Atomoxetine for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents. Cochrane Database of Systematic Reviews 2012, Issue 4. Art. No.: CD009804. DOI: 10.1002/14651858.CD009804